China’s Volume-Based Procurement (VBP) program has reshaped the medtech landscape, driving price cuts of 60 %–90 % across many device categories after five years in force.

In this video briefing, L.E.K. Partner Grace Wang distils what comes next for manufacturers — from capturing rapid hospital uptake and pivoting to premium portfolios to redesigning channels and influencing tender rules.

Watch the video to hear Grace’s practical guidance on defending value and seizing growth in post-VBP China.

L.E.K. Consulting is a registered trademark of L.E.K. Consulting LLC. All other products and brands mentioned in this document are properties of their respective owners. © 2025 L.E.K. Consulting LLC

Related Insights